GlassScriptPhysician profile
Todd C Richter
NPI 1366580466
$5,055.58
in general payments reported to CMS, 2019-2025
25 companies · $881 in 2025
The $881 reported for 2025 was more than what 78% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $721 · 2022: $1,212 · 2023: $1,154 · 2024: $1,088 · 2025: $881.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,122.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,906.00 | 2021-2025 | Proclaim, Octrode, Ionicrf |
| Abiomed | $606.30 | 2025 | |
| Boston Scientific Corporation | $459.11 | 2023-2025 | Wavewriter Alpha Prime 16, Entrada, Infinion 16 |
| Collegium Pharmaceutical, INC. | $229.39 | 2021-2024 | Xtampza |
| Relievant Medsystems, INC. | $153.16 | 2022-2023 | Intracept |
| Abbvie INC. | $109.13 | 2022-2024 | |
| Pfizer INC. | $83.81 | 2021-2024 | |
| Lundbeck LLC | $64.25 | 2022 | |
| Biodelivery Sciences International, INC. | $48.28 | 2021 | |
| Medtronic, INC. | $44.29 | 2021 | |
| Nalu Medical, INC. | $43.34 | 2023-2024 | Nalu Neurostimulation System |
| Atricure, INC. | $41.56 | 2025 | Synergy Ablation System |
| Painteq LLC | $40.92 | 2022 | |
| Almatica Pharma LLC | $31.41 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $25.00 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $23.09 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Edwards Lifesciences Corporation | $22.75 | 2025 | Sapien 3 Ultra Resilia |
| Amgen INC. | $20.44 | 2021 | |
| Si-Bone, INC. | $19.26 | 2024 | |
| Cardiva Medical, INC. | $18.86 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Allergan, INC. | $17.94 | 2021 | |
| Indivior INC. | $14.05 | 2022 | |
| Arbor Pharmaceuticals, INC. | $13.79 | 2021 | |
| Shockwave Medical, INC | $13.70 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $5.75 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Richter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.